Wang W - Search Results

1

(+)-9-Trifluoroethoxy-α-Dihydrotetrabenazine as a Highly Potent Vesicular Monoamine Transporter 2 Inhibitor for Tardive Dyskinesia.

Wang W, Du G, Lin S, Liu J, Yang H, Yu D, Ye L, Zou F, Wang H, Zhang R, Tian J. Wang W, et al. Among authors: wang h. Front Pharmacol. 2021 Dec 7;12:770377. doi: 10.3389/fphar.2021.770377. eCollection 2021. Front Pharmacol. 2021. PMID: 34950030 Free PMC article.

2

Tris-(2,3-Dibromopropyl) Isocyanurate, a New Emerging Pollutant, Impairs Cognition and Provokes Depression-Like Behaviors in Adult Rats.

Ye L, Hu Z, Wang H, Zhu H, Dong Z, Jiang W, Zhao H, Li N, Mi W, Wang W, Hu X. Ye L, et al. Among authors: wang h, wang w. PLoS One. 2015 Oct 12;10(10):e0140281. doi: 10.1371/journal.pone.0140281. eCollection 2015. PLoS One. 2015. PMID: 26458255 Free PMC article.

3

DCT015, a new sorafenib derivate, inhibits tumor growth and angiogenesis in gastric cancer models.

Wang W, Wang H, Ni Y, Yao Z, Ye L, Tian J. Wang W, et al. Among authors: wang h. Tumour Biol. 2016 Jul;37(7):9221-32. doi: 10.1007/s13277-016-4826-3. Epub 2016 Jan 15. Tumour Biol. 2016. PMID: 26768619

4

Combinatorial antitumor effects of indoleamine 2,3-dioxygenase inhibitor NLG919 and paclitaxel in a murine B16-F10 melanoma model.

Meng X, Du G, Ye L, Sun S, Liu Q, Wang H, Wang W, Wu Z, Tian J. Meng X, et al. Among authors: wang h, wang w. Int J Immunopathol Pharmacol. 2017 Sep;30(3):215-226. doi: 10.1177/0394632017714696. Epub 2017 Jun 12. Int J Immunopathol Pharmacol. 2017. PMID: 28604143 Free PMC article.

5

Determination of kynurnine and tryptophan, biomarkers of indoleamine 2,3-dioxygenase by LC-MS/MS in plasma and tumor.

Wang W, Zhuang X, Liu W, Dong L, Sun H, Du G, Ye L. Wang W, et al. Bioanalysis. 2018 Aug 1;10(16):1335-1344. doi: 10.4155/bio-2018-0041. Epub 2018 Aug 21. Bioanalysis. 2018. PMID: 30130131

6

Pharmacokinetics of S-EPA, and its inhibition on indoleamine 2,3-dioxgenase: a case of sulfur-substitution affecting distributions in blood cells.

Wang W, Zhuang X, Sun H, Dong L, Liu Z, Du G, Ye L, Tian J. Wang W, et al. Xenobiotica. 2019 Nov;49(11):1338-1343. doi: 10.1080/00498254.2018.1546024. Epub 2018 Dec 17. Xenobiotica. 2019. PMID: 30507339

7

PCC0208017, a novel small-molecule inhibitor of MARK3/MARK4, suppresses glioma progression in vitro and in vivo.

Li F, Liu Z, Sun H, Li C, Wang W, Ye L, Yan C, Tian J, Wang H. Li F, et al. Among authors: wang h, wang w. Acta Pharm Sin B. 2020 Feb;10(2):289-300. doi: 10.1016/j.apsb.2019.09.004. Epub 2019 Sep 18. Acta Pharm Sin B. 2020. PMID: 32082974 Free PMC article.

8

PCC0208025 (BMS202), a small molecule inhibitor of PD-L1, produces an antitumor effect in B16-F10 melanoma-bearing mice.

Hu Z, Yu P, Du G, Wang W, Zhu H, Li N, Zhao H, Dong Z, Ye L, Tian J. Hu Z, et al. Among authors: wang w. PLoS One. 2020 Mar 26;15(3):e0228339. doi: 10.1371/journal.pone.0228339. eCollection 2020. PLoS One. 2020. PMID: 32214351 Free PMC article.

9

PCC0208023, a potent SHP2 allosteric inhibitor, imparts an antitumor effect against KRAS mutant colorectal cancer.

Chen X, Zou F, Hu Z, Du G, Yu P, Wang W, Wang H, Ye L, Tian J. Chen X, et al. Among authors: wang h, wang w. Toxicol Appl Pharmacol. 2020 Jul 1;398:115019. doi: 10.1016/j.taap.2020.115019. Epub 2020 Apr 24. Toxicol Appl Pharmacol. 2020. PMID: 32335126

10

Discovery of the Next-Generation Pan-TRK Kinase Inhibitors for the Treatment of Cancer.

Liu Z, Yu P, Dong L, Wang W, Duan S, Wang B, Gong X, Ye L, Wang H, Tian J. Liu Z, et al. Among authors: wang h, wang w, wang b. J Med Chem. 2021 Jul 22;64(14):10286-10296. doi: 10.1021/acs.jmedchem.1c00712. Epub 2021 Jul 12. J Med Chem. 2021. PMID: 34253025

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89,574 results

Search Page

Filters